Articles related to RESPIRATORY HEALTH
Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease
In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.
Internal Medicine January 24th 2024
CDC Recommends RSV Vaccine Abrysvo for Use During Pregnancy to Protect Infants
ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.
Allergy & Immunology October 4th 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.
Allergy & Immunology July 27th 2023